Ocrevus Zunovo ocrelizumab 920 mg and hyaluronidase-ocsq 23,000 units /23 mL Images
Generic Name: hyaluronidase/ocrelizumab
This medication has been identified as Ocrevus Zunovo ocrelizumab 920 mg and hyaluronidase-ocsq 23,000 units /23 mL. It is supplied by Genentech, Inc.
Ocrevus Zunovo is used in the treatment of Multiple Sclerosis.
Images of medication
Ocrevus Zunovo
- Generic Name
- hyaluronidase/ocrelizumab
- Strength
- ocrelizumab 920 mg and hyaluronidase-ocsq 23,000 units /23 mL
- Availability
- Prescription only
- CSA Schedule
- Unknown
- Labeler / Supplier
- Genentech, Inc.
- National Drug Code (NDC)
- 50242-0554
More about Ocrevus Zunovo (hyaluronidase / ocrelizumab)
Patient resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
